211
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Update on models of pulmonary fibrosis therapy for preclinical drug research

, MD PhD & , MD PhD
Pages 939-946 | Published online: 20 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesco Varone, Giuliano Montemurro, Francesco Macagno, Mariarosaria Calvello, Emanuele Conte, Enrica Intini, Bruno Iovene, Paolo Maria Leone, Pier-Valerio Mari & Luca Richeldi. (2017) Investigational drugs for idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs 26:9, pages 1019-1031.
Read now

Articles from other publishers (3)

Ben A. Calvert, Zareeb Lorenzana, Christiana N. Senger, Che-Yu Hsu, Shana N. Busch, Sinem Koc-Gunel, Erik J. Quiroz & Amy L. Ryan. 2022. Novel Concepts in iPSC Disease Modeling. Novel Concepts in iPSC Disease Modeling 1 58 .
Jun Tashiro, Gustavo A. Rubio, Andrew H. Limper, Kurt Williams, Sharon J. Elliot, Ioanna Ninou, Vassilis Aidinis, Argyrios Tzouvelekis & Marilyn K. Glassberg. (2017) Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. Frontiers in Medicine 4.
Crossref
Richard P. Marshall, Juliet K. Simpson & Pauline T. Lukey. (2013) Strategies for biomarker discovery in fibrotic disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:7, pages 1079-1087.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.